Mechanism of nucleoside uptake in rat placenta and induction of placental CNT2 in experimental diabetes

Drug Metabolism and Pharmacokinetics

Volumn 27, Issue 4, 2012, Pages 439-446

  Nishimura, Tomohiro ^a   Chishu, Takuya ^a   Tomi, Masatoshi ^a   Nakamura, Ryo ^a   Sato, Kazuko ^a   Kose, Noriko ^a   Sai, Yoshimichi ^a,b   Nakashima, Emi ^a  

^a KEIO UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Antivirals; Diabetes; Drug distribution; Membrane permeability; Nucleosides; Placenta; SLC28; SLC29; Transporters

Indexed keywords

ADENOSINE DERIVATIVE; COMPLEMENTARY RNA; CONCENTRATIVE NUCLEOSIDE TRANSPORTER 2; CONCENTRATIVE NUCLEOSIDE TRANSPORTER 3; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; MESSENGER RNA; NITROBENZYLTHIOINOSINE; NUCLEOSIDE; NUCLEOSIDE TRANSPORTER; PRASTERONE SULFATE; STREPTOZOCIN; UNCLASSIFIED DRUG; URIDINE; ZIDOVUDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRUSH BORDER VESICLE; CLEARANCE; CONTROLLED STUDY; EXPERIMENTAL RAT; FEMALE; INTRAUTERINE GROWTH RETARDATION; MATERNAL DIABETES MELLITUS; NONHUMAN; OOCYTE; PLACENTA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; STREPTOZOCIN DIABETES; TISSUE DISTRIBUTION; XENOPUS;

EID: 84865399782     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-11-RG-103     Document Type: Article

References (42)

1. Gray, J. H., Owen, R. P. and Giacomini, K. M.: The concentrative nucleoside transporter family, SLC28. Pflugers Arch., 447: 728-734 (2004).
2. Baldwin, S. A., Beal, P. R., Yao, S. Y., King, A. E., Cass, C. E. and Young, J. D.: The equilibrative nucleoside transporter family, SLC29. Pflugers Arch., 447: 735-743 (2004).
3. Tomi, M., Nishimura, T. and Nakashima, E.: Mother-to-fetus transfer of antiviral drugs and the involvement of transporters at the placental barrier. J. Pharm. Sci., 100: 3708-3718 (2011).
4. Yao, S. Y., Ng, A. M., Sundaram, M., Cass, C. E., Baldwin, S. A. and Young, J. D.: Transport of antiviral 3$-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2. nucleoside transporter proteins produced in Xenopus oocytes. Mol. Membr. Biol., 18: 161-167 (2001).
5. Barros, L. F., Yudilevich, D. L., Jarvis, S. M., Beaumont, N., Young, J. D. and Baldwin, S. A.: Immunolocalisation of nucleoside transporters in human placental trophoblast and endothelial cells: evidence for multiple transporter isoforms. Pflugers Arch., 429: 394-399 (1995).
6. Govindarajan, R., Bakken, A. H., Hudkins, K. L., Lai, Y., Casado, F. J., Pastor-Anglada, M., Tse, C. M., Hayashi, J. and Unadkat, J. D.: In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol., 293: R1809-R1822 (2007).
7. Barros, L. F., Bustamante, J. C., Yudilevich, D. L. and Jarvis, S. M.: Adenosine transport and nitrobenzylthioinosine binding in human placental membrane vesicles from brush-border and basal sides of the trophoblast. J. Membr. Biol., 119: 151-161 (1991).
8. Nishimura, M. and Naito, S.: Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab. Pharmacokinet., 20: 452-477 (2005).
9. Sato, K., Sai, Y., Nishimura, T., Chishu, T., Shimpo, S., Kose, N. and Nakashima, E.: Influx mechanism of 2$,3$-dideoxyinosine and uridine at the blood-placenta barrier. Placenta, 30: 263-269 (2009).
10. Sai, Y., Nishimura, T., Shimpo, S., Chishu, T., Sato, K., Kose, N., Terasaki, T., Mukai, C., Kitagaki, S., Miyakoshi, N., Kang, Y. S. and Nakashima, E.: Characterization of the mechanism of zidovudine uptake by rat conditionally immortalized syncytiotrophoblast cell line TR-TBT. Pharm. Res., 25: 1647-1653 (2008).
11. Nishimura, T., Seki, Y., Sato, K., Chishu, T., Kose, N., Terasaki, T., Kang, Y. S., Sai, Y. and Nakashima, E.: Enhancement of zidovudine uptake by dehydroepiandrosterone sulfate in rat syncytiotrophoblast cell line TR-TBT 18d-1. Drug Metab. Dispos., 36: 2080-2085 (2008).
12. Chishu, T., Sai, Y., Nishimura, T., Sato, K., Kose, N. and Nakashima, E.: Potential of various drugs to inhibit nucleoside uptake in rat syncytiotrophoblast cell line, TR-TBT 18d-1. Placenta, 29: 461-467 (2008).
13. Kitano, T., Iizasa, H., Terasaki, T., Asashima, T., Matsunaga, N., Utoguchi, N., Watanabe, Y., Obinata, M., Ueda, M. and Nakashima, E.: Polarized glucose transporters and mRNA expression properties in newly developed rat syncytiotrophoblast cell lines, TR-TBTs. J. Cell. Physiol., 193: 208-218 (2002).
14. Higuchi, K., Iizasa, H., Sai, Y., Horieya, S., Lee, K. E., Wada, M., Deguchi, M., Nishimura, T., Wakayama, T., Tamura, A., Tsukita, S., Kose, N., Kang, Y. S. and Nakashima, E.: Differential expression of ezrin and CLP36 in the two layers of syncytiotrophoblast in rats. Biol. Pharm. Bull., 33: 1400-1406 (2010).
15. Sai, Y., Nishimura, T., Ochi, K., Tanaka, N., Takagi, A., Tomi, M., Kose, N., Kobayashi, Y., Miyakoshi, N., Kitagaki, S., Mukai, C. and Nakashima, E.: Proton-coupled erythromycin antiport at rat blood-placenta barrier. Drug Metab. Dispos., 38: 1576-1581 (2010).
16. Nishimura, T., Sai, Y., Fujii, J., Muta, M., Iizasa, H., Tomi, M., Deureh, M., Kose, N. and Nakashima, E.: Roles of TauT and system A in cytoprotection of rat syncytiotrophoblast cell line exposed to hypertonic stress. Placenta, 31: 1003-1009 (2010).
17. Escudero, C., Casanello, P. and Sobrevia, L.: Human equilibrative nucleoside transporters 1 and 2 may be differentially modulated by A2B adenosine receptors in placenta microvascular endothelial cells from pre-eclampsia. Placenta, 29: 816-825 (2008).
18. San Martín, R. and Sobrevia, L.: Gestational diabetes and the adenosine/L-arginine/nitric oxide (ALANO. pathway in human umbilical vein endothelium. Placenta, 27: 1-10 (2006).
19. López-Soldado, I. and Herrera, E.: Different diabetogenic response to moderate doses of streptozotocin in pregnant rats, and its longterm consequences in the offspring. Exp. Diabesity Res., 4: 107-118 (2003).
20. Yoneyama, Y., Sawa, R., Suzuki, S., Shin, S., Power, G. G. and Araki, T.: The relationship between uterine artery Doppler velocimetry and umbilical venous adenosine levels in pregnancies complicated by preeclampsia. Am. J. Obstet. Gynecol., 174: 267-271 (1996).
21. Escudero, C. and Sobrevia, L.: A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. Placenta, 29: 469-483 (2008).
22. Pawelczyk, T., Podgorska, M. and Sakowicz, M.: The effect of insulin on expression level of nucleoside transporters in diabetic rats. Mol. Pharmacol., 63: 81-88 (2003).
23. Osses, N., Sobrevia, L., Cordova, C., Jarvis, S. M. and Yudilevich, D. L.: Transport and metabolism of adenosine in diabetic human placenta. Reprod. Fertil. Dev., 7: 1499-1503 (1995).
24. Smith, C. H., Nelson, D. M., King, B. F., Donohue, T. M., Ruzycki, S. and Kelley, L. K.: Characterization of a microvillous membrane preparation from human placental syncytiotrophoblast: a morphologic, biochemical, and physiologic, study. Am. J. Obstet. Gynecol., 128: 190-196 (1977).
25. Alonso de la Torre, S. R., Serrano, M. A., Alvarado, F. and Medina, J. M.: Carrier-mediated L-lactate transport in brushborder membrane vesicles from rat placenta during late gestation. Biochem. J., 278(Pt 2): 535-541 (1991).
26. Moyer, M. S., Insler, N. and Dumaswala, R.: The role of chloride in taurine transport across the human placental brush-border membrane. Biochim. Biophys. Acta, 1109: 74-80 (1992).
27. Baldwin, S. A., Yao, S. Y., Hyde, R. J., Ng, A. M., Foppolo, S., Barnes, K., Ritzel, M. W., Cass, C. E. and Young, J. D.: Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3. located in intracellular membranes. J. Biol. Chem., 280: 15880-15887 (2005).
28. Govindarajan, R., Leung, G. P., Zhou, M., Tse, C. M., Wang, J. and Unadkat, J. D.: Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. Am. J. Physiol. Gastrointest. Liver Physiol., 296: G910-G922 (2009).
29. Nishimura, T., Tanaka, J., Tomi, M., Seki, Y., Kose, N., Sai, Y. and Nakashima, E.: Enhancement of zidovudine transfer to molt-4 cells, a human t-cell model, by dehydroepiandrosterone sulfate. J. Pharm. Sci., 100: 3959-3967 (2011).
30. Liebes, L., Mendoza, S., Wilson, D. and Dancis, J.: Transfer of zidovudine (AZT. by human placenta. J. Infect. Dis., 161: 203-207 (1990).
31. Schenker, S., Johnson, R. F., King, T. S., Schenken, R. S. and Henderson, G. I.: Azidothymidine (zidovudine. transport by the human placenta. Am. J. Med. Sci., 299: 16-20 (1990).
32. Lopez-Anaya, A., Unadkat, J. D., Schumann, L. A. and Smith, A. L.: Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer. J. Acquir. Immune Defic. Syndr., 3: 959-964 (1990).
33. Coan, P. M., Angiolini, E., Sandovici, I., Burton, G. J., Constancia, M. and Fowden, A. L.: Adaptations in placental nutrient transfer capacity to meet fetal growth demands depend on placental size in mice. J. Physiol., 586: 4567-4576 (2008).
34. Wang, J., Su, S. F., Dresser, M. J., Schaner, M. E., Washington, C. B. and Giacomini, K. M.: Na({pipe})-dependent purine nucleoside transporter from human kidney: cloning and functional characterization. Am. J. Physiol., 273: F1058-F1065 (1997).
35. Che, M., Ortiz, D. F. and Arias, I. M.: Primary structure and functional expression of a cDNA encoding the bile canalicular, purine-specific Na({pipe})-nucleoside cotransporter. J. Biol. Chem., 270: 13596-13599 (1995).
36. Podgorska, M., Kocbuch, K., Grden, M., Szutowicz, A. and Pawelczyk, T.: Prevalence of unidirectional Na{pipe}-dependent adenosine transport and altered potential for adenosine generation in diabetic cardiac myocytes. Basic Res. Cardiol., 101: 214-222 (2006).
37. Podgorska, M., Kocbuch, K., Grden, M., Szutowicz, A. and Pawelczyk, T.: Reduced ability to release adenosine by diabetic rat cardiac fibroblasts due to altered expression of nucleoside transporters. J. Physiol., 576: 179-189 (2006).
38. Sobrevía, L., Jarvis, S. M. and Yudilevich, D. L.: Adenosine transport in cultured human umbilical vein endothelial cells is reduced in diabetes. Am. J. Physiol., 267: C39-C47 (1994).
39. Aguayo, C., Casado, J., Gonzalez, M., Pearson, J. D., Martin, R. S., Casanello, P., Pastor-Anglada, M. and Sobrevia, L.: Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia. Placenta, 26: 641-653 (2005).
40. Vásquez, G., Sanhueza, F., Vasquez, R., Gonzalez, M., San Martin, R., Casanello, P. and Sobrevia, L.: Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J. Physiol., 560: 111-122 (2004).
41. Vega, J. L., Puebla, C., Vasquez, R., Farias, M., Alarcon, J., Pastor-Anglada, M., Krause, B., Casanello, P. and Sobrevia, L.: TGF-beta1 inhibits expression and activity of hENT1 in a nitric oxide-dependent manner in human umbilical vein endothelium. Cardiovasc. Res., 82: 458-467 (2009).
42. Casanello, P., Torres, A., Sanhueza, F., Gonzalez, M., Farias, M., Gallardo, V., Pastor-Anglada, M., San Martin, R. and Sobrevia, L.: Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium. Circ. Res., 97: 16-24 (2005).